Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5603/ARM.a2020.0191 http://scihub22266oqcxt.onion/10.5603/ARM.a2020.0191 33559122!ä!33559122 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Adv+Respir+Med 2021 ; 89 (1): 90-91 Nephropedia Template TP {{tp|p=33559122|t=2021. Risk assessment and prognostic aspect of coagulopathy in COVID-19 |pdf=|usr=}}{{33559122}} gab.com Text Risk assessment and prognostic aspect of coagulopathy in COVID-19 JO: Adv Respir Med http://www.kidney.de/pget.php?&tw=1&pmid=33559122 #FOAvip Since December 2019, the rapid spread of SARS CoV-2 across the border, shuffled into a world pandemic situation with an alarming rate of morbidity and mortality. Concerns are mounting as the reports indicate tangled circumstances among the COVID-19 patients due to blood coagulopathy followed by organ dysfunction. COVID-19 induced an alteration in coagulation function increase the risk of pulmonary embolism and deep vein thrombosis associated with poor prognosis as well as high mortality. An elevated level D-dimer and other fibrin degrading protein are documented among the patients with COVID-19; especially in severe cases. Differences in coagulopathy among severe and non-severe cases, required prompt attention to adopt a more effective management strategy. Twit Text FOAVip Risk assessment and prognostic aspect of coagulopathy in COVID-19 ????Adv Respir Med http://www.kidney.de/pget.php?&tw=1&pmid=33559122 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33559122 #FOAvip English Wikipedia <ref>{{Cite pmid|33559122}}</ref> Risk assessment and prognostic aspect of coagulopathy in COVID-19 #MMPMID33559122 Rahman M; Rakhi NN Adv Respir Med 2021[]; 89 (1): 90-91 PMID33559122show ga Since December 2019, the rapid spread of SARS CoV-2 across the border, shuffled into a world pandemic situation with an alarming rate of morbidity and mortality. Concerns are mounting as the reports indicate tangled circumstances among the COVID-19 patients due to blood coagulopathy followed by organ dysfunction. COVID-19 induced an alteration in coagulation function increase the risk of pulmonary embolism and deep vein thrombosis associated with poor prognosis as well as high mortality. An elevated level D-dimer and other fibrin degrading protein are documented among the patients with COVID-19; especially in severe cases. Differences in coagulopathy among severe and non-severe cases, required prompt attention to adopt a more effective management strategy. |Blood Coagulation Disorders/epidemiology/*metabolism[MESH] |COVID-19/*complications/epidemiology/metabolism[MESH] |Fibrin Fibrinogen Degradation Products/*metabolism[MESH] |Humans[MESH] |Incidence[MESH] |Prognosis[MESH]Risk assessment and prognostic aspect of coagulopathy in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing